Loosening the belt on magnetic sphincter augmentation indications: does body mass index matter?

• Published in: Surgical endoscopy Vol. 36; no. 7; pp. 4878 - 4884
• Main Authors: James, Tayler J., Burke, Jocelyn F., Putnam, Luke R., Pan, Jennifer, Bildzukewicz, Nikolai A., Bell, Reginald, Lipham, John C.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.07.2022; Springer Nature B.V
• Subjects: Abdominal Surgery; Body Mass Index; Esophageal Sphincter, Lower - surgery; Female; Gastroenterology; Gastroesophageal reflux; Gastroesophageal Reflux - complications; Gastroesophageal Reflux - surgery; Gynecology; Hepatology; Hernia, Hiatal - surgery; Hiatal hernias; Humans; Laparoscopy; Magnetic Phenomena; Medicine; Medicine & Public Health; Obesity; Obesity - surgery; Overweight; Overweight - complications; Overweight - surgery; Patients; Proctology; Quality of Life; Retrospective Studies; Surgery; Treatment Outcome; Obesity; LINX; Magnetic sphincter augmentation; Gastroesophageal reflux disease
• DOI: 10.1007/s00464-021-08839-7
• ISSN: 0930-2794

Background Magnetic sphincter augmentation (MSA) is an effective treatment for gastroesophageal reflux disease (GERD). However, the impact of obesity on MSA outcomes is unknown. The objective of this study was to evaluate the effectiveness of MSA in patients with GERD and obesity. Methods A retrospective cohort study was performed of consecutive patients who underwent laparoscopic MSA at three high-volume centers from 2016 to 2019. Patients were grouped into four cohorts according to the World Health Organization body mass index (BMI) classification: BMI < 25 (normal weight), BMI 25–29.9 (overweight), BMI 30–34.9 (obese class I), and BMI > 35 (obese class II–III). Preoperative, operative, and postoperative data were compared between groups. Results A total of 621 patients underwent laparoscopic MSA during the study period. Follow-up with endoscopy or video esophagram was available for 361 patients (58%) with a median follow-up of 15.4 months. Baseline characteristics of the groups were similar except the BMI > 35 group had more females and a higher preoperative median DeMeester score. There were no significant differences in outcomes between normal weight, overweight, and obese patient groups undergoing MSA. All groups experienced significant reductions in acid suppressive medication use, low GERD-HRQL scores, low DeMeester scores, few intraoperative and postoperative complications, and low rates of hiatal hernia recurrence after MSA. Conclusions Magnetic sphincter augmentation is safe and effective in improving GERD symptoms, reducing esophageal acid exposure, and preventing hiatal hernia recurrence, irrespective of patient BMI. MSA should be considered an acceptable treatment option for obese patients with GERD.